Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital MarketsGlobeNewsWire • 10/09/25
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 09/30/25
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 08/14/25
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/15/25
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADCGlobeNewsWire • 04/25/25
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology ForumGlobeNewsWire • 04/02/25
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025GlobeNewsWire • 03/25/25
Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 03/18/25
Pyxis Oncology to Participate at the Leerink Partners Global Healthcare ConferenceGlobeNewsWire • 03/03/25
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck CancerGlobeNewsWire • 02/26/25
Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy TrialGlobeNewsWire • 02/04/25
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201GlobeNewsWire • 12/19/24
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 DataGlobeNewsWire • 11/20/24
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% UpsideBenzinga • 11/08/24
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS)PRNewsWire • 09/25/24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024GlobeNewsWire • 08/14/24